Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Standerlink (Beijing) Biopharmaceutical Technology is a specialized Contract Research Organization (CRO) based in China that focuses on pharmaceutical analysis and quality research. The company provides comprehensive services for generic drug consistency evaluation, impurity profiling, and stability testing to ensure compliance with regulatory standards. Standerlink operates advanced laboratory facilities equipped with high-end analytical instrumentation for structural characterization and method validation. Their expertise is particularly tailored to the technical requirements of the Chinese National Medical Products Administration (NMPA) for drug registration and approval. By offering specialized R&D support, Standerlink facilitates the development and market entry of high-quality pharmaceutical products for its clients. The company is recognized as a National High-tech Enterprise and serves as a key technical partner for numerous domestic pharmaceutical manufacturers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Standerlink.